Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Tiziana Life Sciences to launch phase 2 trial of Foralumab in Covid-19 Tiziana Life Sciences said that it plans to launch a phase 2 clinical trial to evaluate the nasal… bySrinathMarch 30, 2021
